Literature DB >> 17919358

How do people with gastro-oesophageal reflux disease perceive their disease? Results of a multinational survey.

Philippe Ducrotté1, Harley R Liker.   

Abstract

OBJECTIVE: To determine how patients with gastro-oesophageal reflux disease (GERD) perceive their condition.
METHODS: Subjects with a formal diagnosis of GERD (n = 929) and those who did not have a formal diagnosis but regularly suffered from symptoms suggestive of GERD (heartburn or acid regurgitation, n = 924) were identified as part of a multinational survey.
RESULTS: Symptoms had been present for a mean of 11 years in diagnosed individuals and 8 years in undiagnosed individuals. Over-the-counter (OTC) antacids were used by 78% of undiagnosed individuals. Most patients (68% of undiagnosed and 46% of diagnosed subjects) did not consider themselves to have a serious condition, while 70% of undiagnosed and 58% of diagnosed respondents believed that their condition would not have any long-term health consequences. A key perception driving the decision to seek medical care was the belief that a physician, and prescribed medication, could help. Conversely, the perception that OTC medications work effectively was the greatest barrier to visiting a physician. Diagnosed patients, who, on average, waited 2 years before seeking medical advice, indicated that prescription medication reduced the severity and frequency of their symptoms.
CONCLUSIONS: There is widespread perception that GERD is a non-serious disease without long-term health consequences, and some patients find that OTC medications are a sufficiently effective treatment option. Educational initiatives should perhaps be targeted at those in greatest medical need, overcoming the barriers that dissuade many of these patients from seeking appropriate medical care.

Entities:  

Mesh:

Year:  2007        PMID: 17919358     DOI: 10.1185/030079907x233412

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  5 in total

1.  Patient satisfaction with switching to esomeprazole from existing proton pump inhibitor therapy for gastro-oesophageal reflux disease: an observational, multicentre study.

Authors:  Robert J Hoogendoorn; Lex Groeneveld; J Andy Kwee
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

2.  GERD prevalence in migraine patients and the implication for acute migraine treatment.

Authors:  Bozena J Katić; Wendy Golden; Roger K Cady; X Henry Hu
Journal:  J Headache Pain       Date:  2008-11-14       Impact factor: 7.277

3.  Unmet Needs in the Treatment of Gastroesophageal Reflux Disease.

Authors:  Ram Dickman; Carla Maradey-Romero; Rachel Gingold-Belfer; Ronnie Fass
Journal:  J Neurogastroenterol Motil       Date:  2015-07-30       Impact factor: 4.924

4.  Understanding gastro-oesophageal reflux disease: a patient-cluster analysis.

Authors:  A King; C MacDonald; C Orn
Journal:  Int J Clin Pract       Date:  2008-12       Impact factor: 2.503

5.  Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising.

Authors:  Bridget J Kelly; Douglas J Rupert; Kathryn J Aikin; Helen W Sullivan; Mihaela Johnson; Carla M Bann; Nicole Mack; Brian G Southwell; Sue West; Sarah Parvanta; Alexander Rabre; Susana Peinado
Journal:  Res Social Adm Pharm       Date:  2020-08-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.